DID. Dunbar Ivy

D. Dunbar Ivy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


D. Dunbar Ivy has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Steven H. Abman

    5 shared publications
  • Cheryl E. Gariepy

    Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75235

    3 shared publications
  • Ivan F. McMurtry

    Cardiovascular Pulmonary Research Laboratory, University of Colorado School of Medicine, and The Children's Hospital, Denver, Colorado 80218; and

    3 shared publications
  • Masashi Yanagisawa

    Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas 75235

    3 shared publications
  • Sarah A. Gebb

    Cardiovascular Pulmonary Research Laboratory, University of Colorado School of Medicine, and The Children's Hospital, Denver, Colorado 80218; and

    3 shared publications
  • Thomas A. Parker

    3 shared publications

Latest Publications

  • Brain Natriuretic Peptide Levels in Managing Pediatric Patients With Pulmonary Arterial Hypertension

    by Anna Bernus, Brandie D. Wagner, Frank Accurso, Aimee Doran, Heidi Kaess, D. Dunbar Ivy


  • Stiffening of the Extrapulmonary Arteries From Rats in Chronic Hypoxic Pulmonary Hypertension

    by E. S Drexler, J. E Bischoff, A. J Slifka, C. N McCowan, T. P Quinn, R Shandas, D. D Ivy, K. R Stenmark

    Changes in the compliance properties of large blood vessels are critical determinants of ventricular afterload and ultimately dysfunction. Little is known of the mechanical properties of large vessels exhibiting pulmonary hypertension, particularly the trunk and right main artery. We initiated a study to investigate the influence of chronic hypoxic pulmonary hypertension on the mechanical properties of the extrapulmonary arteries of rats. One group of animals was housed at the equivalent of 5000 m elevation for three weeks and the other held at ambient conditions of ~1600 m. The two groups were matched in age and gender. The animals exposed to hypobaric hypoxia exhibited signs of pulmonary hypertension, as evidenced by an increase in the RV/(LV+S) heart weight ratio. The extrapulmonary arteries of the hypoxic animals were also thicker than those of the control population. Histological examination revealed increased thickness of the media and additional deposits of collagen in the adventitia. The mechanical properties of the trunk, and the right and left main pulmonary arteries were assessed; at a representative pressure (7 kPa), the two populations exhibited different quantities of stretch for each section. At higher pressures we noted less deformation among the arteries from hypoxic animals as compared with controls. A four-parameter constitutive model was employed to fit and analyze the data. We conclude that chronic hypoxic pulmonary hypertension is associated with a stiffening of all the extrapulmonary arteries.


  • Endothelin B Receptor Blockade Attenuates Pulmonary Vasodilation in Oxygen-Ventilated Fetal Lambs

    by D. Dunbar Ivy, Dong-Seok Lee, Robyn L. Rairigh, Thomas A. Parker, Steven H. Abman

    Background: Endothelin-1 (ET-1) contributes to the regulation of pulmonary vascular tone in the normal ovine fetus and in models of perinatal pulmonary hypertension. In the fetal lamb lung, the effects of ET-1 depend on the balance of at least two endothelin receptor subtypes: ETA and ETB. ETA receptors are located on smooth muscle cells and mediate vasoconstriction and smooth muscle proliferation. Stimulation of endothelial ETB receptors causes vasodilation through release of nitric oxide and also functions to remove ET-1 from the circulation. However, whether activation of ETB receptors contributes to the fall in pulmonary vascular tone at birth is unknown. Objective and Methods: To determine the role of acute ETB receptor blockade in pulmonary vasodilation in response to birth-related stimuli, we studied the hemodynamic effects of selective ETB receptor blockade with BQ-788 during mechanical ventilation with low (<10%) and high FiO2 (100%) in near-term fetal sheep. Results: Intrapulmonary infusion of BQ-788 did not change left pulmonary artery (LPA) blood flow and pulmonary vascular resistance (PVR) at baseline. In comparison with controls, BQ-788 treatment attenuated the rise in LPA flow with low and high FiO2 ventilation (p < 0.001 vs. control for each FiO2 concentration). PVR progressively decreased during mechanical ventilation with low and high FiO2 in both groups, but PVR remained higher after BQ-788 treatment throughout the study period (p < 0.001). Conclusions: We conclude that selective ETB receptor blockade attenuates pulmonary vasodilation at birth. We speculate that ETB receptor stimulation contributes to pulmonary vasodilation at birth in the ovine fetus.


  • Neonatal Aortic Arch Thrombosis Masquerading as Coarctation of the Aorta

    by B. B. Das, S. Sahoo, D. D. Ivy

    We report two neonates with thrombosis of the aortic arch and isthmus diagnosed by echocardiography. Neonatal transient protein C deficiency was present in one patient and the other patient had severe perinatal asphyxia. Both patients presented with markedly reduced left ventricular function and severe aortic obstruction. In one infant, the thrombus was successfully removed surgically, and the second infant died due to serious complications of perinatal asphyxia.


  • Exaggerated hypoxic pulmonary hypertension in endothelin B receptor-deficient rats

    by D. Dunbar Ivy, Masashi Yanagisawa, Cheryl E. Gariepy, Sarah A. Gebb, Kelley L. Colvin, Ivan F. McMurtry

    Mechanisms by which endothelin (ET)-1 mediates chronic pulmonary hypertension remain incompletely understood. Although activation of the ET type A (ETA) receptor causes vasoconstriction, stimulation of ET type B (ETB) receptors can elicit vasodilation or vasoconstriction. We hypothesized that the ETB receptor attenuates the development of hypoxic pulmonary hypertension and studied a genetic rat model of ETB receptor deficiency (transgenic sl/sl). After 3 wk of severe hypoxia, the transgenic sl/sl pulmonary vasculature lacked expression of mRNA for the ETB receptor and developed exaggerated pulmonary hypertension that was characterized by elevated pulmonary arterial pressure, diminished cardiac output, and increased total pulmonary resistance. Plasma ET-1 was fivefold higher in transgenic sl/sl rats than in transgenic controls. Although mRNA for prepro-ET-1 was not different, mRNA for ET-converting enzyme-1 was higher in transgenic sl/sl than in transgenic control lungs. Hypertensive lungs of sl/sl rats also produced less nitric oxide metabolites and 6-ketoprostaglandin F1α, a metabolite of prostacyclin, than transgenic controls. These findings suggest that the ETB receptor plays a protective role in the pulmonary hypertensive response to chronic hypoxia.


  • Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction

    by D. Dunbar Ivy, Ivan F. McMurtry, Masashi Yanagisawa, Cheryl E. Gariepy, Timothy D. Le Cras, Sarah A. Gebb, Kenneth G. Morris, Richard C. Wiseman, Steven H. Abman

    Endothelin (ET)-1 contributes to the regulation of pulmonary vascular tone by stimulation of the ETA and ETB receptors. Although activation of the ETA receptor causes vasoconstriction, stimulation of the ETB receptors can elicit either vasodilation or vasoconstriction. To examine the physiological role of the ETB receptor in the pulmonary circulation, we studied a genetic rat model of ETB receptor deficiency [transgenic( sl/ sl)]. We hypothesized that deficiency of the ETB receptor would predispose the transgenic( sl/ sl) rat lung circulation to enhanced pulmonary vasoconstriction. We found that the lungs of transgenic( sl/ sl) rats are ETBdeficient because they lack ETB mRNA in the pulmonary vasculature, have minimal ETB receptors as determined with an ET-1 radioligand binding assay, and lack ET-1-mediated pulmonary vasodilation. The transgenic( sl/ sl) rats have higher basal pulmonary arterial pressure and vasopressor responses to brief hypoxia or ET-1 infusion. Plasma ET-1 levels are elevated and endothelial nitric oxide synthase protein content and nitric oxide production are diminished in the transgenic( sl/ sl) rat lung. These findings suggest that the ETB receptor plays a major physiological role in modulating resting pulmonary vascular tone and reactivity to acute hypoxia. We speculate that impaired ETB receptor activity can contribute to the pathogenesis of pulmonary hypertension.


  • Prolonged endothelin B receptor blockade causes pulmonary hypertension in the ovine fetus

    by D. Dunbar Ivy, Thomas A. Parker, Steven H. Abman, Jason Gien, Nancy Tseng, Gregory Seedorf, Katherine Kuhn, Yuansheng Gao, J. Usha Raj, Stephen Wedgwood, et al.

    Endothelin (ET)-1 contributes to regulation of pulmonary vascular tone and structure in the normal ovine fetus and in models of perinatal pulmonary hypertension. The hemodynamic effects of ET-1 are due to activation of its receptors. The ETAreceptor mediates vasoconstriction and smooth muscle cell proliferation, whereas the ETBreceptor mediates vasodilation. In a lamb model of chronic intrauterine pulmonary hypertension, ETBreceptor activity and gene expression are decreased. To determine whether prolonged ETBreceptor blockade causes pulmonary hypertension, we studied the hemodynamic effects of selective ETBreceptor blockade with BQ-788. Animals were treated with an infusion of either BQ-788 or vehicle for 7 days. Prolonged BQ-788 treatment increased pulmonary arterial pressure and pulmonary vascular resistance ( P < 0.05). The pulmonary vasodilator response to sarafotoxin 6c, a selective ETBreceptor agonist, was attenuated after 7 days of BQ-788 treatment, demonstrating pharmacological blockade of the ETBreceptor. Animals treated with BQ-788 had greater right ventricular hypertrophy and muscularization of small pulmonary arteries ( P < 0.05). Lung ET-1 levels were threefold higher in the animals treated with BQ-788 ( P < 0.05). We conclude that prolonged selective ETBreceptor blockade causes severe pulmonary hypertension and pulmonary vascular remodeling in the late-gestation ovine fetus.


  • Open Access

    Developmental changes in endothelin expression and activity in the ovine fetal lung

    by D. Dunbar Ivy, Timothy D. le Cras, Thomas A. Parker, Jeanne P. Zenge, Malathi Jakkula, Neil E. Markham, John P. Kinsella, Steven H. Abman

    Mechanisms that regulate endothelin (ET) in the perinatal lung are complex and poorly understood, especially with regard to the role of ET before and after birth. We hypothesized that the ET system is developmentally regulated and that the balance of ETAand ETBreceptor activity favors vasoconstriction. To test this hypothesis, we performed a series of molecular and physiological studies in the fetal lamb, newborn lamb, and adult sheep. Lung preproET-1 mRNA levels, tissue ET peptide levels, and cellular localization of ET-1 expression were determined by Northern blot analysis, peptide assay, and immunohistochemistry in distal lung tissue from fetal lambs between 70 and 140 days (term = 145 days), newborn lambs, and ewes. Lung mRNA expression for the ETAand ETBreceptors was also measured at these ages. We found that preproET-1 mRNA expression increased from 113 to 130 days gestation. Whole lung ET protein content was highest at 130 days gestation but decreased before birth in the fetal lamb lung. Immunolocalization of ET-1 protein showed expression of ET-1 in the vasculature and bronchial epithelium at all gestational ages. ETAreceptor mRNA expression and ETBreceptor mRNA increased from 90 to 125 and 135 days gestation. To determine changes in activity of the ETAand ETBreceptors, we studied the effect of selective antagonists to the ETAor ETBreceptors at 120, 130, and 140 days of fetal gestation. ETAreceptor-mediated vasoconstriction increased from 120 to 140 days, whereas blockade of the ETBreceptor did not change basal fetal pulmonary vascular tone at any age examined. We conclude that the ET system is developmentally regulated and that the increase in ETAreceptor gene expression correlates with the onset of the vasodilator response to ETAreceptor blockade. Although ETBreceptor gene expression increases during late gestation, the balance of ET receptor activity favors vasoconstriction under basal conditions. We speculate that changes in ET receptor activity play important roles in regulation of pulmonary vascular tone in the ovine fetus.


  • Open Access

    Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus.

    by D D Ivy, T A Parker, J W Ziegler, H L Galan, J P Kinsella, R M Tuder, S H Abman

    Based on past studies of an experimental model of severe intrauterine pulmonary hypertension, we hypothesized that endothelin-1 (ET-1) contributes to high pulmonary vascular resistance (PVR), hypertensive lung structural changes, and right ventricular hypertrophy (RVH) caused by prolonged closure of the ductus arteriosus. To test this hypothesis, we studied the effects of BQ 123, a selective ET(A) receptor antagonist, after ligation of the ductus arteriosus in utero. In 19 late gestation fetal lambs (126+/-3 d; 147 d, term) we ligated the ductus arteriosus at surgery, and treated animals with either BQ 123 (1 mg/d) or vehicle (0.1% DMSO, HTN) in the pulmonary artery for 8 d. Chronic BQ 123 treatment attenuated the rise in mean pulmonary artery pressure (PAP) 8 d after ductus arteriosus ligation (78+/-2, HTN vs. 70+/-4 mmHg, BQ 123, P < 0.05). To study the effects of ET(A) blockade at birth, 15 animals were delivered by cesarean section and ventilated with 10% oxygen (O2), 100% O2 and inhaled nitric oxide (NO). Lambs treated with BQ 123 had lower PVR after delivery during ventilation with 10% O2, 100% O2, and inhaled NO (HTN vs. BQ 123, P < 0.05 for each intervention). Acute BQ 123 treatment (2 mg/30 min) lowered PVR in three HTN animals ventilated with 100% O2 and inhaled NO (P < 0.05). Chronic BQ 123 treatment prevented the development of RVH as determined by the ratio of the right ventricle/left ventricle + septum (0.79+/-0.03, HTN vs. 0.57+/-0.06, BQ 123, P < 0.05) and attenuated the increase in wall thickness of small pulmonary arteries (61+/-2, HTN vs. 50+/-2%, BQ 123, P < 0.05). In summary, chronic intrauterine ET(A) receptor blockade decreased PAP in utero, decreased RVH and distal muscularization of small pulmonary arteries, and increased the fall in PVR at delivery. We conclude that ET(A) receptor stimulation contributes to the pathogenesis and pathophysiology of experimental perinatal pulmonary hypertension.